PHARMACOKINETICS AND SAFETY OF A NOVEL APOLIPOPROTEIN A-I THERAPY, CSL112, IN ADULTS WITH MODERATE RENAL IMPAIRMENT (RI) AND NORMAL RENAL FUNCTION
CLINICAL PHARMACOLOGY & THERAPEUTICS(2017)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2017)